CDMRP – Toxic Exposures Research Program Clinical Trial Partnership Award
Expire le 29 juillet 2025
The intent of the FY25 Toxic Exposures Research Program Clinical Trial Partnership Award is to support new or existing collaborative partnerships that will rapidly implement clinical trials with the potential to have a significant impact on the prevention, treatment or management of symptoms, diseases, or conditions associated with or resulting from military-related toxic exposures. Proposed projects may range from small proof-of-concept clinical trials (e.g., pilot, first-in-human, phase 0) designed to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials (including pragmatic clinical trials) to determine efficacy in relevant patient populations.